Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
出版年份 2021 全文链接
标题
Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-11
DOI
10.3389/fimmu.2021.747594
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
- (2021) Antonio M Risitano et al. Lancet Haematology
- From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors
- (2021) Dimitrios C. Mastellos et al. CLINICAL IMMUNOLOGY
- Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
- (2021) Rachel H. Bhak et al. CURRENT MEDICAL RESEARCH AND OPINION
- Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms
- (2020) Lisa A. Lewis et al. FEBS LETTERS
- MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab
- (2020) S. Elhadad et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
- (2020) Richard Lafayette et al. Kidney International Reports
- C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
- (2020) Carlos Castro et al. AMERICAN JOURNAL OF HEMATOLOGY
- Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19
- (2020) Wioleta M. Zelek et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bacterial killing by complement requires membrane attack complex formation via surface‐bound C5 convertases
- (2019) Dani AC Heesterbeek et al. EMBO JOURNAL
- Differential effects of therapeutic complement Inhibitors on serum bactericidal activity against nongroupable meningococcal isolates recovered from patients treated with eculizumab
- (2019) Dan M. Granoff et al. HAEMATOLOGICA
- Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
- (2019) Anna Schubart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical promise of next-generation complement therapeutics
- (2019) Dimitrios C. Mastellos et al. NATURE REVIEWS DRUG DISCOVERY
- How the Membrane Attack Complex Damages the Bacterial Cell Envelope and Kills Gram‐Negative Bacteria
- (2019) Dennis J. Doorduijn et al. BIOESSAYS
- Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies
- (2019) Carine El Sissy et al. Frontiers in Immunology
- A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy
- (2019) Austin Kulasekararaj et al. BLOOD
- Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab
- (2018) Anja Gäckler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications
- (2018) Dani A.C. Heesterbeek et al. Journal of Innate Immunity
- A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies
- (2018) Peter T Beernink et al. JOURNAL OF INFECTIOUS DISEASES
- The renaissance of complement therapeutics
- (2017) Daniel Ricklin et al. Nature Reviews Nephrology
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
- (2017) Lucy A. McNamara et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40
- (2016) Junxiang Wang et al. CLINICAL IMMUNOLOGY
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Skipping of exon 27 in C3 gene compromises TED domain and results in complete human C3 deficiency
- (2016) Karina Ribeiro da Silva et al. IMMUNOBIOLOGY
- From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage
- (2016) Dimitrios C. Mastellos et al. IMMUNOBIOLOGY
- New milestones ahead in complement-targeted therapy
- (2016) Daniel Ricklin et al. SEMINARS IN IMMUNOLOGY
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Applying complement therapeutics to rare diseases
- (2015) Edimara S. Reis et al. CLINICAL IMMUNOLOGY
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
- (2015) Dimitrios C. Mastellos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Serum bactericidal antibody assays – The role of complement in infection and immunity
- (2015) E.D.G. McIntosh et al. VACCINE
- Cellular and molecular biology ofNeisseria meningitidiscolonization and invasive disease
- (2015) Darryl J. Hill et al. CLINICAL SCIENCE
- Randomized Clinical Trial To Evaluate the Immunogenicity of Quadrivalent Meningococcal Conjugate and Polysaccharide Vaccines in Adults in the United Kingdom
- (2014) Maheshi N. Ramasamy et al. Clinical and Vaccine Immunology
- Deficiency in Complement Factor B
- (2013) Charlotte Slade et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningococcal disease and the complement system
- (2013) Lisa A Lewis et al. Virulence
- The tick-over theory revisited: Is C3 a contact-activated protein?
- (2012) Bo Nilsson et al. IMMUNOBIOLOGY
- Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein
- (2011) Serena Giuntini et al. INFECTION AND IMMUNITY
- ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study
- (2010) A. Sié et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Meningococcal carriage and disease—Population biology and evolution
- (2009) Dominique A. Caugant et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More